Evolution of adverse drug reactions reporting systems: paper based to software based
- 5 July 2022
- journal article
- review article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 78 (9) , 1385-1390
Abstract
Objective Adverse Drug Reactions (ADR) add a significant clinical and economic burden to the healthcare system of a country. We present an overview of the different approaches of ADR reporting systems worldwide and their evolution over time. Methods A systematic review of the literature was made based on PubMed and the Cochrane database of systematic reviews. The articles searched for included original articles, WHO and FDA reports and institute of medicine reports. Summary Reporting ADRs is the cornerstone of detecting uncommon ADRs once the drugs are on the market. In many countries, ADR reporting is regulated by national regulatory bodies and various methods are employed to report ADRs. Direct reporting by healthcare professionals has been adopted by many developed and developing countries. With emerging new technologies in the field of medicine, there is a great potential to develop better ADR reporting systems in the countries where they have poor reporting. Conclusion Development and acquisition of newer technologies to promote ADR monitoring and reporting is a necessity for an effective pharmacovigilance system in a country.Keywords
All Related Versions
This publication has 21 references indexed in Scilit:
- Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literatureBMC Medicine, 2016
- Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®Drug Safety, 2016
- Experiences and Lessons From Implementing Cohort Event Monitoring Programmes for Antimalarials in Four African Countries: Results of a Questionnaire-Based SurveyDrug Safety, 2015
- Adverse Drug Reaction Reporting by Patients: An Overview of Fifty CountriesDrug Safety, 2014
- Pharmacovigilance in AsiaJournal of Pharmacology and Pharmacotherapeutics, 2013
- Workshop- and Telephone-Based Interventions to Improve Adverse Drug Reaction ReportingDrug Safety, 2012
- Thalidomide: The Tragedy of Birth Defects and the Effective Treatment of DiseaseToxicological Sciences, 2011
- Improving reporting of adverse drug reactions: Systematic reviewClinical Epidemiology, 2009
- Pharmacovigilance in the pharmaceutical industryBritish Journal of Clinical Pharmacology, 1998
- Incidence of Adverse Drug Reactions in Hospitalized PatientsJAMA, 1998